Most Likely Diagnosis: Clostridioides difficile Infection (CDI)
The most likely diagnosis in this patient is Clostridioides difficile infection (CDI), given the classic presentation of chronic diarrhea, nausea, vomiting, and weight loss following multiple courses of doxycycline. 1
Rationale for CDI as Primary Diagnosis
The FDA drug label for doxycycline explicitly warns that Clostridioides difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including doxycycline, and may range in severity from mild diarrhea to fatal colitis 1. The mechanism involves alteration of normal colonic flora leading to C. difficile overgrowth and toxin production 1.
Critical features supporting this diagnosis:
- Three courses of doxycycline create cumulative risk for disrupting gut microbiome
- Chronic diarrhea, nausea, vomiting align with CDAD spectrum
- Weight loss indicates severity and chronicity
- CDAD can occur up to two months after antibiotic administration 2
Diagnostic Approach
Immediate testing should use a two-stage approach 2:
- First stage: Glutamate dehydrogenase enzyme immunoassay (EIA), nucleic acid amplification testing, or PCR to identify organism presence
- Second stage: Toxin EIA to demonstrate active toxin production
This combination provides high negative and positive predictive values. Where results disagree, clinical judgment determines treatment need 2.
Critical Differential Diagnoses to Exclude
While CDI is most likely, the presentation warrants systematic exclusion of other seronegative enteropathies:
Celiac Disease
Mandatory serological testing with tissue transglutaminase IgA plus total IgA level 2, 3. Celiac disease prevalence in chronic diarrhea patients ranges 3-10% in secondary care 2. However, the patient must be consuming gluten (1-3 slices of bread daily) for accurate testing 4. If already avoiding gluten, testing becomes unreliable.
Giardiasis
Given chronic symptoms, stool ELISA for Giardia (92% sensitivity, 98% specificity) should be performed 2. This parasitic infection causes chronic diarrhea, weight loss, and abdominal symptoms 4. Treatment is metronidazole if positive 4.
Tropical Sprue
Notably, tropical sprue is treated with tetracycline or doxycycline plus folic acid 4. If the patient improved temporarily on doxycycline then relapsed after stopping, this becomes more likely. However, travel to endemic areas is required 4.
Whipple's Disease
This rare condition presents with chronic diarrhea, weight loss, and abdominal pain 5, 6. Diagnosis requires upper endoscopy with duodenal biopsy showing PAS-positive macrophages 4. Treatment involves ceftriaxone followed by doxycycline and hydroxychloroquine 5. The fact that symptoms persist despite doxycycline makes this less likely.
Management Algorithm
If CDI is suspected or confirmed, discontinue doxycycline immediately 1. Management includes:
- Fluid and electrolyte replacement
- Protein supplementation
- Antibiotic treatment directed against C. difficile (not continuation of doxycycline)
- Surgical evaluation if clinically indicated 1
Additional Workup if CDI Negative
If C. difficile testing is negative, proceed with:
- Fecal calprotectin to evaluate for inflammatory bowel disease 3
- Colonoscopy with random biopsies for microscopic colitis (affects 13% of chronic diarrhea patients) 3, especially given alarm features of weight loss
- Upper endoscopy with duodenal biopsies to evaluate for celiac disease (even if serology negative, as 6.4-7% are antibody-negative) 2, Whipple's disease, giardiasis, and other enteropathies 4
Common Pitfalls
Do not assume post-infectious IBS after C. difficile without confirming eradication 2. The phenomenon of post-infectious IBS after CDI is recognized, but active infection must be excluded first.
Do not test for celiac disease if patient has already reduced gluten intake - results will be unreliable 4. Require 1-3 months of gluten consumption before testing.
Do not rely solely on stool ova and parasite examination (only 60-90% sensitive) - use Giardia-specific ELISA if suspicion remains 2.